HR 5605 · 115th Congress · Health
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Finance.(2018-06-20)
Plain Language Summary
[AI summary unavailable — showing source text]
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access of opioid use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures. Opioid use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participating teams. The CMS must adopt or develop program quality standards and performance methods.…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 5605, Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Jun 11, 2018As ordered reported by the House Committee on Energy and Commerce on May 17, 2018
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office